Iridocyclitis – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Thu, 28 May 2026 11:32:16 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Iridocyclitis – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study to evaluate the effect of upadacitinib on the frequency of eye inflammation in patients with axial spondyloarthritis. https://clinicaltrials.eu/trial/study-to-evaluate-the-effect-of-upadacitinib-on-the-frequency-of-eye-inflammation-in-patients-with-axial-spondyloarthritis/ Wed, 29 Apr 2026 15:09:27 +0000 https://clinicaltrials.eu/trial/study-to-evaluate-the-effect-of-upadacitinib-on-the-frequency-of-eye-inflammation-in-patients-with-axial-spondyloarthritis/ This study aims to evaluate how upadacitinib affects the occurrence of eye inflammation in people living with Axial Spondyloarthritis. Axial Spondyloarthritis is a type of long-term inflammatory disease that primarily affects the spine and the joints around it. Some individuals with this condition also experience Acute Anterior Uveitis, which is a sudden inflammation inside the front part of the eye that can cause redness, pain, and vision changes.

Participants in this research will be given upadacitinib, which is an oral medication taken in the form of a prolonged-release tablet. This type of pill is designed to release the medicine slowly into the body over time. The study will follow the participants over a period of 52 weeks to observe how frequently episodes of eye inflammation occur while taking the medication.

]]>